10x Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	490.29	473.97	344.07	359.28	219.75	587.45
Short-Term Investments	49.56	49.44	49.34	29.41	212.87	1.03
Cash & Short-Term Investments	539.85	523.41	393.4	388.7	432.62	588.48
Cash Growth	26.46%	33.05%	1.21%	-10.15%	-26.48%	-13.48%
Accounts Receivable	39.03	47.01	87.86	114.83	104.21	85.25
Other Receivables	17.11	35.48	0.61	-	-	-
Total Trade Receivables	56.14	82.49	88.47	114.83	104.21	85.25
Inventory	53.49	56.34	83.11	73.71	81.63	59.97
Other Current Assets	20.26	22.21	19.41	18.79	16.58	13.9
Total Current Assets	669.73	684.45	584.39	596.02	635.04	747.59
Net Property, Plant & Equipment	278.98	287.16	309.94	344.93	359.21	230.41
Other Intangible Assets	59.91	62.33	15.67	16.62	22.86	25.4
Goodwill	4.51	4.51	4.51	4.51	4.51	4.51
Other Long-Term Assets	2.62	2.91	4.13	3.06	7.37	10.92
Total Assets	1,016	1,041	918.64	965.14	1,029	1,019
Accounts Payable	17.43	12.73	12.91	15.74	21.6	17.35
Accrued Expenses	55.19	82.47	74.78	86.75	92.45	82.54
Current Portion of Leases	11.33	10.99	9.29	11.52	9.04	5.13
Unearned Revenue	24.34	23.9	20.66	13.15	7.87	5.34
Other Current Liabilities	5.32	23.36	-	-	-	-
Total Current Liabilities	113.6	153.45	117.63	127.16	130.96	110.36
Long-Term Leases	70.06	73.38	73.33	83.85	86.14	76.85
Other Long-Term Liabilities	17.78	18.21	17.54	13.09	6.14	14.05
Total Long-Term Liabilities	87.84	91.59	90.87	96.94	92.28	90.9
Total Liabilities	201.44	245.04	208.5	224.1	223.24	201.26
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	2,338	2,307	2,178	2,026	1,839	1,681
Accumulated Other Comprehensive Income	0.11	0.23	-0.49	-0.43	-4.34	0.02
Retained Earnings	-1,524	-1,511	-1,467	-1,284	-1,029	-863.32
Shareholders' Equity	814.32	796.33	710.13	741.04	805.74	817.57
Total Liabilities & Equity	1,016	1,041	918.64	965.14	1,029	1,019
Total Debt	81.39	84.36	82.61	95.37	95.18	81.98
Net Cash (Debt)	458.46	439.05	310.79	293.33	337.44	506.5
Net Cash Growth	4.42%	41.27%	5.95%	-13.07%	-33.38%	-17.94%
Net Cash Per Share	3.63	3.52	2.58	2.50	2.96	4.59
Book Value	814.32	796.33	710.13	741.04	805.74	817.57
Book Value Per Share	6.45	6.38	5.90	6.32	7.08	7.41
Tangible Book Value	749.9	729.49	689.95	719.92	778.37	787.66
Tangible Book Value Per Share	5.94	5.85	5.73	6.14	6.84	7.14

SEC Filings: 10-K · 10-Q